Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

A leukemia therapy that Novartis (NVS) bought from the University of Pennsylvania has freed nine...

  • Monday, December 10, 2012, 8:07 AM ET
    A leukemia therapy that Novartis (NVS) bought from the University of Pennsylvania has freed nine out of 12 patients of the blood cancer. The treatment works by taking the sufferers' immune cells, reprogramming them to target leukemia cells, and then re-injecting them into the patients. Novartis will call the treatment CTL019.
Track new comments on this story

This news story has 1 comment:

  •  
    The real news is the patients in the trial all failed standard treatment
    10 Dec 2012, 08:15 AM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »